GB0210605D0 — A fluid dispensing device
Assigned to Glaxo Group Ltd · Expires 2002-06-19 · 24y expired
What this patent protects
A fluid dispenser (5, 105)is disclosed having a housing (9, 109)and a pump action fluid discharge device (8, 108). The pump action fluid discharge device (8, 108) is arranged to be actuated by a pair of opposing levers (20, 21); (120, 121) which are pivotally connected to part of…
USPTO Abstract
A fluid dispenser (5, 105)is disclosed having a housing (9, 109)and a pump action fluid discharge device (8, 108). The pump action fluid discharge device (8, 108) is arranged to be actuated by a pair of opposing levers (20, 21); (120, 121) which are pivotally connected to part of the housing (9, 109). When the levers (20, 21); (120, 121) are squeezed together the fluid discharge device (8, 108) is urged towards a nozzle (11, 111) causing a single dose of fluid to be dispensed from the nozzle (11, 111).
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.